University of Oulu
oulu.fiTotal trials
140
Active
19
Phase 3
4
Total enrollment
64,559
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Prednisolone Sodium Phosphate | — | — | — | — | — | 1 | |
| Sugar syrup | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | — | 1 | |
| Fentanyl | — | — | — | — | — | 1 | |
| Salbutamol | — | — | — | — | — | 1 |
Next readouts
- 2025-10-31
- 2026-12
- 2026-12
Top conditions
- Obesity6
- Anxiety5
- Pain4
- Coronary Artery Disease3
- Fear3
- Type 1 Diabetes3
- Trauma3
- Surgery2
Frequently asked questions about University of Oulu
- How many clinical trials does University of Oulu have on ClinicalTrials.gov?
- University of Oulu is listed as the lead sponsor on 140 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Oulu's trials are in Phase 3?
- 4 of University of Oulu's trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does University of Oulu focus on?
- University of Oulu's most-studied conditions on ClinicalTrials.gov are Obesity, Anxiety, Pain, Coronary Artery Disease, Fear.
- When are University of Oulu's next clinical trial readouts?
- University of Oulu has 3 upcoming primary-completion readouts tracked here; the soonest is “Premedication for Less Invasive Surfactant Administration”, expected around 2025-10-31.